Cite
HARVARD Citation
Juarez, M. et al. (n.d.). AB0458 A PHASE II RANDOMISED, DOUBLE-BLIND, PLACEBO-CONTROLLED, PROOF OF CONCEPT STUDY OF ORAL SELETALISIB IN PATIENTS WITH PRIMARY SJÖGREN'S SYNDROME (PSS). Annals of the rheumatic diseases. pp. 1692-1693. [Online].